el-Shami K, Smith BD (2008) Immunotherapy for myeloid leukemias: current status and future directions. Leukemia 22:1658–1664
CAS
Article
PubMed
Google Scholar
Corm S, Berthon C, Imbenotte M, Biggio V, Lhermitte M, Dupont C, Briche I, Quesnel B (2009) Indoleamine 2, 3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients’ sera by HPLC and is inducible by IFN-gamma. Leuk Res 33:490–494
CAS
Article
PubMed
Google Scholar
Curti A, Pandolfi S, Valzasina B, Aluigi M, Isidori A, Ferri E, Salvestrini V, Bonanno G, Rutella S, Durelli I, Horenstein AL, Fiore F, Massaia M, Colombo MP, Baccarani M, Lemoli RM (2007) Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. Blood 109:2871–2877
CAS
PubMed
Google Scholar
Saudemont A, Hamrouni A, Marchetti P, Liu J, Jouy N, Hetuin D, Colucci F, Quesnel B (2007) Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1. Cancer Res 67:4491–4498
CAS
Article
PubMed
Google Scholar
Saudemont A, Jouy N, Hetuin D, Quesnel B (2005) NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood 105:2428–2435
CAS
Article
PubMed
Google Scholar
Saudemont A, Quesnel B (2004) In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis. Blood 104:2124–2133
CAS
Article
PubMed
Google Scholar
Quesnel B (2008) Dormant tumor cells as a therapeutic target? Cancer Lett 267:10–17
CAS
Article
PubMed
Google Scholar
Liu J, Joha S, Idziorek T, Corm S, Hetuin D, Philippe N, Preudhomme C, Quesnel B (2008) BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism. Leukemia 22:791–799
CAS
Article
PubMed
Google Scholar
Wei S, Shreiner AB, Takeshita N, Chen L, Zou W, Chang AE (2008) Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta. Cancer Res 68:5432–5438
CAS
Article
PubMed
Google Scholar
Keir ME, Butte MJ, Freeman GJ, Sharpe AH (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26:677–704
CAS
Article
PubMed
Google Scholar
Butte MJ, Pena-Cruz V, Kim MJ, Freeman GJ, Sharpe AH (2008) Interaction of human PD-L1 and B7-1. Mol Immunol 45:3567–3572
CAS
Article
PubMed
Google Scholar
Zou W, Chen L (2008) Inhibitory B7-family molecules in the tumour microenvironment. Nature Rev 8:467–477
CAS
Article
Google Scholar
Liu J, Hamrouni A, Wolowiec D, Coiteux V, Kuliczkowski K, Hetuin D, Saudemont A, Quesnel B (2007) Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway. Blood 110:296–304
CAS
Article
PubMed
Google Scholar
Vereecque R, Buffenoir G, Gonzalez R, Preudhomme C, Fenaux P, Quesnel B (1999) A new murine aggressive leukemic model. Leuk Res 23:415–416
CAS
Article
PubMed
Google Scholar
Saudemont A, Corm S, Wickham T, Hetuin D, Quesnel B (2005) Induction of leukemia-specific CD8+ cytotoxic T cells with autologous myeloid leukemic cells maturated with a fiber-modified adenovirus encoding TNF-alpha. Mol Ther 11:950–959
CAS
Article
PubMed
Google Scholar
Tamura H, Dan K, Tamada K, Nakamura K, Shioi Y, Hyodo H, Wang SD, Dong H, Chen L, Ogata K (2005) Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia. Clin Cancer Res 11:5708–5717
CAS
Article
PubMed
Google Scholar
Vereecque R, Buffenoir G, Gonzalez R, Cambier N, Hetuin D, Bauters F, Fenaux P, Quesnel B (2000) Gamma-ray irradiation induces B7.1 expression in myeloid leukaemic cells. Br J Haematol 108:825–831
CAS
Article
PubMed
Google Scholar
Vereecque R, Saudemont A, Quesnel B (2004) Cytosine arabinoside induces costimulatory molecule expression in acute myeloid leukemia cells. Leukemia 18:1223–1230
CAS
Article
PubMed
Google Scholar
Parsa AT, Waldron JS, Panner A, Crane CA, Parney IF, Barry JJ, Cachola KE, Murray JC, Tihan T, Jensen MC, Mischel PS, Stokoe D, Pieper RO (2007) Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med 13:84–88
CAS
Article
PubMed
Google Scholar
Stripecke R, Levine AM, Pullarkat V, Cardoso AA (2002) Immunotherapy with acute leukemia cells modified into antigen-presenting cells: ex vivo culture and gene transfer methods. Leukemia 16:1974–1983
CAS
Article
PubMed
Google Scholar
Buggins AG, Lea N, Gaken J, Darling D, Farzaneh F, Mufti GJ, Hirst WJ (1999) Effect of costimulation and the microenvironment on antigen presentation by leukemic cells. Blood 94:3479–3490
CAS
PubMed
Google Scholar
Barrett AJ, Savani BN (2009) Does chemotherapy modify the immune surveillance of hematological malignancies? Leukemia 23:53–58
CAS
Article
PubMed
Google Scholar
Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ (2007) Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27:111–122
CAS
Article
PubMed
Google Scholar
Xerri L, Chetaille B, Seriari N, Attias C, Guillaume Y, Arnoulet C, Olive D (2008) Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Hum Pathol 39:1050–1058
CAS
Article
PubMed
Google Scholar
Kozako T, Yoshimitsu M, Fujiwara H, Masamoto I, Horai S, White Y, Akimoto M, Suzuki S, Matsushita K, Uozumi K, Tei C, Arima N (2009) PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients. Leukemia 23:375–382
CAS
Article
PubMed
Google Scholar
Salih HR, Wintterle S, Krusch M, Kroner A, Huang YH, Chen L, Wiendl H (2006) The role of leukemia-derived B7-H1 (PD-L1) in tumor-T-cell interactions in humans. Exp Hematol 34:888–894
CAS
Article
PubMed
Google Scholar
Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, Krzysiek R, Knutson KL, Daniel B, Zimmermann MC, David O, Burow M, Gordon A, Dhurandhar N, Myers L, Berggren R, Hemminki A, Alvarez RD, Emilie D, Curiel DT, Chen L, Zou W (2003) Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 9:562–567
CAS
Article
PubMed
Google Scholar
Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, Wood CR, Greenfield EA, Freeman GJ (2003) Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 170:1257–1266
CAS
PubMed
Google Scholar
Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8:793–800
CAS
PubMed
Google Scholar
Allam JP, WM Peng, T Appel, M Wenghoefer, B Niederhagen, T Bieber, S Berge and N Novak (2008) Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells. J Allerg Clin Immunol 121:368-374 e361
Google Scholar
Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH, Mayer L, Unkeless JC, Xiong H (2005) Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 65:5009–5014
CAS
Article
PubMed
Google Scholar
Chiron D, Bekeredjian-Ding I, Pellat-Deceunynck C, Bataille R, Jego G (2008) Toll-like receptors: lessons to learn from normal and malignant human B cells. Blood 112:2205–2213
CAS
Article
PubMed
Google Scholar
Webb RN, Cruse JM, Lewis RE (2007) Differential cytokine and Toll-like receptor expression in leukemia. Exp Mol Pathol 83:464–470
CAS
Article
PubMed
Google Scholar
Spaner DE, Shi Y, White D, Mena J, Hammond C, Tomic J, He L, Tomai MA, Miller RL, Booth J, Radvanyi L (2006) Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells. Leukemia 20:286–295
CAS
Article
PubMed
Google Scholar
Abbas S, Abu-Amer Y (2003) Dominant-negative IkappaB facilitates apoptosis of osteoclasts by tumor necrosis factor-alpha. J Biol Chem 278:20077–20082
CAS
Article
PubMed
Google Scholar
Spaner DE, Foley R, Galipeau J, Bramson J (2008) Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies. Oncogene 27:208–217
CAS
Article
PubMed
Google Scholar
Spaner DE, Masellis A (2007) Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia. Leukemia 21:53–60
CAS
Article
PubMed
Google Scholar
Corthals SL, Wynne K, She K, Shimizu H, Curman D, Garbutt K, Reid GS (2006) Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia. Br J Haematol 132:452–458
CAS
PubMed
Google Scholar
Lehner M, Bailo M, Stachel D, Roesler W, Parolini O, Holter W (2007) Caspase-8 dependent apoptosis induction in malignant myeloid cells by TLR stimulation in the presence of IFN-alpha. Leuk Res 31:1729–1735
CAS
Article
PubMed
Google Scholar
Marcucci G, Radmacher MD, Maharry K, Mrozek K, Ruppert AS, Paschka P, Vukosavljevic T, Whitman SP, Baldus CD, Langer C, Liu CG, Carroll AJ, Powell BL, Garzon R, Croce CM, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD (2008) MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 358:1919–1928
CAS
Article
PubMed
Google Scholar
Chambers SM, Goodell MA (2007) Hematopoietic stem cell aging: wrinkles in stem cell potential. Stem Cell Rev 3:201–211
CAS
Article
PubMed
Google Scholar
Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA (2007) Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 5:e201
Article
PubMed
Google Scholar
Qian Y, Deng J, Geng L, Xie H, Jiang G, Zhou L, Wang Y, Yin S, Feng X, Liu J, Ye Z, Zheng S (2008) TLR4 signaling induces B7-H1 expression through MAPK pathways in bladder cancer cells. Cancer Invest 26:816–821
CAS
Article
PubMed
Google Scholar
Lee SK, Seo SH, Kim BS, Kim CD, Lee JH, Kang JS, Maeng PJ, Lim JS (2005) IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells. J Dermatol Sci 40:95–103
CAS
Article
PubMed
Google Scholar
Crane CA, Panner A, Murray JC, Wilson SP, Xu H, Chen L, Simko JP, Waldman FM, Pieper RO, Parsa AT (2008) PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer. Oncogene 28:306–312
Article
PubMed
Google Scholar